CSD vs. GERM ETF Comparison
Comparison of Guggenheim Spin-Off ETF (CSD) to ETFMG Treatments Testing and Advancements ETF (GERM)
CSD
Guggenheim Spin-Off ETF
CSD Description
The investment seeks investment results that correspond generally to the performance, before the fund's fees and expenses, of an equity index called the Beacon Spin-off Index. The fund invests at least 90% of its assets in common stock, ADRs and MLPs that comprise the index and depositary receipts representing common stocks included in the index. It generally will invest in all of the securities comprising the index in proportion to their weightings in the index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$80.40
Average Daily Volume
916
24
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.Grade (RS Rating)
Last Trade
$19.16
Average Daily Volume
1,248
2
Performance
Period | CSD | GERM |
---|---|---|
30 Days | 7.87% | 3.00% |
60 Days | 16.86% | 3.68% |
90 Days | 15.94% | -2.06% |
12 Months | 48.24% | -0.17% |
0 Overlapping Holdings
Symbol | Grade | Weight in CSD | Weight in GERM | Overlap |
---|
CSD Overweight 24 Positions Relative to GERM
Symbol | Grade | Weight | |
---|---|---|---|
CEG | A | 9.35% | |
GEV | A | 8.36% | |
GEHC | C | 7.28% | |
VLTO | A | 7.1% | |
SOLV | C | 5.35% | |
CR | A | 4.62% | |
ESAB | C | 4.62% | |
GXO | D | 4.48% | |
UHAL | C | 4.44% | |
DTM | A | 4.39% | |
KNF | B | 4.37% | |
KD | D | 4.15% | |
OGN | F | 3.87% | |
VNT | F | 3.65% | |
RXO | D | 3.37% | |
NATL | D | 2.38% | |
PHIN | D | 2.15% | |
CNXC | F | 2.1% | |
VSTS | D | 2.06% | |
VSCO | C | 2.02% | |
FTRE | F | 1.97% | |
VMEO | C | 1.03% | |
EMBC | F | 0.92% | |
CCSI | C | 0.35% |
CSD: Top Represented Industries & Keywords
GERM: Top Represented Industries & Keywords